@article {5012,
	title = {Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.},
	journal = {The Journal of infectious diseases},
	year = {2015},
	month = {2015 Dec 17},
	abstract = {  For young South African women at risk for human immunodeficiency virus (HIV) infection, preexposure prophylaxis (PrEP) is one of the few effective prevention options available. Long-acting injectable PrEP, which is in development, may be associated with greater adherence, compared with that for existing standard oral PrEP formulations, but its likely clinical benefits and additional costs are unknown.},
	issn = {1537-6613},
	doi = {10.1093/infdis/jiv523},
	author = {Walensky, Rochelle P and Jacobsen, Margo M and Bekker, Linda-Gail and Parker, Robert A and Wood, Robin and Resch, Stephen C and Horstman, N Kaye and Freedberg, Kenneth A and Paltiel, A David}
}
